Update: Spyre Shares Fall After Pricing $350 Million Stock Offering

MT newswire2026/10/06 19:56

03:56 PM EDT, 10/06/2026 (MT Newswires) -- (Updates with the latest stock price movement in the headline and the first paragraph.) Spyre Therapeutics (SYRE) shares fell over 13% in Tuesday trading after the company priced an underwritten public offering of about 4.1 million shares at $85 apiece to raise about $350 million. Underwriters have a 30-day option to purchase up to an additional $52.5 million of shares, Spyre said late Monday. The firm said it plans to use the net proceeds to advance its programs in gastroenterology, rheumatology, and dermatology, among other things. It expects to close the offering Oct. 7. Price: 80.38, Change: -12.35, Percent Change: -13.31

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Total loss of approximately $38.68 million, with a certain address increasing its btc short positions by about $3.32 million

Odaily星球日报•2026/11/11 01:21

Euro drifts toward the bottom of its range as US rate bets climb

FXStreet•2026/11/10 23:45

Levi Strauss SVP and General Counsel David Jedrzejek reports disposal of $207,493.23 in common shares

Bitget•2026/11/10 23:42

Updated version 3 - As demand for artificial intelligence remains strong, CoreWeave plans to achieve profitability by 2028

路透社•2026/11/10 23:41